<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="726">
  <stage>Registered</stage>
  <submitdate>9/09/2005</submitdate>
  <approvaldate>9/09/2005</approvaldate>
  <nctid>NCT00163553</nctid>
  <trial_identification>
    <studytitle>Neuraxial Pethidine After Lumbar Surgery Trial</studytitle>
    <scientifictitle>Neuraxial Pethidine After Lumbar Surgery Trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>01833</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sciatica</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Pethidine
Treatment: drugs - Placebo

Experimental: P - Epidural pethidine group

Placebo Comparator: N - placebo group


Treatment: drugs: Pethidine


Treatment: drugs: Placebo


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cumulative 24-hour pethidine consumption</outcome>
      <timepoint>24 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient data:</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Age</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Gender</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Body mass index</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Current medications</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Preoperative opioid analgesic use (none, low, high - high dose being &gt; 300 mg codeine or dextropropoxyphene daily or oral morphine or parenteral opioid use)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Compensable status (HNC, TAC, WCV or PMI/SUR) 22</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Surgical data:</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anatomical extent of surgery (number of spinal levels)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Highest anatomical surgical level</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Experience level of primary surgeon (trainee or consultant)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anatomical level of epidural tip (identified from postoperative X-Ray when taken as routine care only)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Dural tear at the time of surgery (yes/no)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Spinal instrumentation (yes/no)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Other end-points (all at 1, 4, 24 and 48 hours unless stated):</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cumulative pethidine dose</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cumulative morphine dose</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>VAS scores for pain at rest and during movement</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Sedation score (1 - 4) 16</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>VAS scores for nausea, pruritis</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Other adverse events: agitation, tremor, hallucinations, seizure</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction scale for pain control during study (48 hours)</outcome>
      <timepoint>48 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>(very dissatisfied, dissatisfied, neutral, satisfied, very satisfied) 17</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Plasma pethidine and norpethidine levels (24 hours)</outcome>
      <timepoint>24 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physiotherapy assessment of ability to deep breathe &amp; cough (unable, poor, adequate, good)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of inpatient stay</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Adults undergoing lumbar spinal surgery</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Lack of informed patient consent

          -  Acute or chronic renal failure

          -  Known allergy or intolerance to pethidine or tramadol

          -  Chronic respiratory insufficiency

          -  Epidural contraindicated (coagulopathy, systemic infection)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/12/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Austin Health - Melbourne</hospital>
    <postcode>3084 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The hypothesis is that epidural pethidine is an effective form of pain relief following
      lumbar spinal surgery, resulting in significantly lower usage of concomitantly administered
      (intravenous) patient-controlled analgesia (PCA) pethidine.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00163553</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dean A Cowie, MBBS, FANZCA</name>
      <address>Austin Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Dean A Cowie, MBBS, FANZCA</name>
      <address />
      <phone>61-3-9496-3227</phone>
      <fax />
      <email>dean.cowie@austin.org.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>